Functional Molecules from Natural Sources

· · ·
· Royal Society of Chemistry
Sách điện tử
244
Trang
Điểm xếp hạng và bài đánh giá chưa được xác minh  Tìm hiểu thêm

Giới thiệu về sách điện tử này

Naturally-occurring compounds have been, and continue to be, an important source of new leads and of commercially successful products for various industrial sectors, notably pharmaceuticals and agrochemicals. The conference, Functional Molecules from Natural Sources, held at Magdalen College, Oxford, in July 2009 set out to highlight current trends, challenges and successes in the exploitation of natural products from microbial, plant and marine sources. Based on the proceedings of this conference, the main themes of this book are modern and emerging perspectives on natural product utilization and improved strategies for natural products exploitation. It provides case studies on important natural product leads (functional molecules) and their enhancement. These take account of new medical applications, and advances in the understanding and manipulation of natural product biosynthesis at the genetic level. Highlights include an authoritative review of the entire field of natural anticancer agents, (with an emphasis on those currently in clinical development); an account of the optimisation of the pleuromutilin antibiotic template for human use, and a comprehensive description of the research programme that resulted in the discovery of platensimycin. Aricles on biosynthesis include studies of the antibiotics of Streptomyces coelicolor A3(2), the anthrax siderophore petrobactin, and the modification of oxidation and glycosylation events in the biosynthesis of mithramycins. Written by leading industrial experts from each sector, the book offers a unique blend of industrial and academic perspectives. It summarizes new approaches to optimising the exploitation of naturally occurring compounds within the pharmaceutical, nutraceutical and agrochemicals industries. New approaches to optimising the exploitation of naturally occurring compounds (including the genetics of natural product biosynthesis), novel screening technologies and recent advances in characterization methods are also covered.

Giới thiệu tác giả

Stephen K. Wrigley has worked in the field of industrial natural products drug discovery and development for twenty five years. He is currently Chief Technical Officer at Hypha Discovery Ltd., where his scientific interests are focused on the identification and evaluation of novel basidiomycete metabolites with anticancer and antimicrobial activities. Prior to joining Hypha, he led efforts to characterize and develop new lipopeptide antibiotics at RecombinoGen Ltd. Steve was formerly Senior Director of Research for Cubist Pharmaceuticals (UK) Ltd., where he led a team engaged in antibiotic screening and participated in programmes to generate improved lipopeptides through chemical and genetic modification. He had previously held research management and scientific positions involving microbial product discovery at TerraGen Discovery, Inc., Xenova Ltd. and Glaxo Group Research Ltd. Steve obtained BSc and PhD degrees, both in chemistry, from Imperial College, University of London, in 1982 and 1985, respectively.

Xếp hạng sách điện tử này

Cho chúng tôi biết suy nghĩ của bạn.

Đọc thông tin

Điện thoại thông minh và máy tính bảng
Cài đặt ứng dụng Google Play Sách cho AndroidiPad/iPhone. Ứng dụng sẽ tự động đồng bộ hóa với tài khoản của bạn và cho phép bạn đọc trực tuyến hoặc ngoại tuyến dù cho bạn ở đâu.
Máy tính xách tay và máy tính
Bạn có thể nghe các sách nói đã mua trên Google Play thông qua trình duyệt web trên máy tính.
Thiết bị đọc sách điện tử và các thiết bị khác
Để đọc trên thiết bị e-ink như máy đọc sách điện tử Kobo, bạn sẽ cần tải tệp xuống và chuyển tệp đó sang thiết bị của mình. Hãy làm theo hướng dẫn chi tiết trong Trung tâm trợ giúp để chuyển tệp sang máy đọc sách điện tử được hỗ trợ.